Skip to main content
Clinical Trials/DRKS00032215
DRKS00032215
Not yet recruiting
Not Applicable

Personalized, predictive, precise & preventive medicine for Major Depression - P4D

Medizinische Hochschule Hannover0 sites1,000 target enrollmentJuly 27, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Major Depressive Disorder MDD (DSM-5) / rezidivierende depressive Störung, gegenwärtig mittelgradig bis schwer (ICD-10: F32.1-3 & F33.1-3) and/or Persistend Depressive Disorder (PDD
Sponsor
Medizinische Hochschule Hannover
Enrollment
1000
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 27, 2023
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Medizinische Hochschule Hannover

Eligibility Criteria

Inclusion Criteria

  • MDD: F32\.1\-3, F33\.1\-3 first or recurrent depressive episode (confirmed by MINI\-DIPS confirmed) and/or PDD: F34\.1
  • \- Symptom severity: Moderate to severe (MADRS \= 20\).
  • \- First depressive episode before 50 years of age
  • \- Signed informed consent form
  • \- Capacity to consent

Exclusion Criteria

  • Acute Suicidality
  • Placement according to state law (e.g. §16/17 Nds. PsychKG)
  • The following diagnoses in the life course: Dementia, schizophrenia,
  • schizoaffective disorder, bipolar disorder, substance dependence with currently necessary detoxification
  • Concurrent participation in other clinical trials that are not being conducted within the framework of the P4D project

Outcomes

Primary Outcomes

Not specified

Similar Trials